EN | TR
E-ISSN: 2980-2679
The Effect of Modified Ultrafiltration Applied After Cardiopulmonary Bypass in Pediatric Open Heart Surgery
PDF
Cite
Share
Request
Research Article
VOLUME: 1 ISSUE: 3
P: 78-84
December 2023

The Effect of Modified Ultrafiltration Applied After Cardiopulmonary Bypass in Pediatric Open Heart Surgery

Turk J Clin Cardiov Perfusion 2023;1(3):78-84
DOI: 10.4274/tjccp.galenos.2023.52724
Esra Özbek
Tarık Demir
1. Sağlık Bilimleri Üniversitesi Başakşehir Çam ve Sakura Şehir Hastanesi, Kalp ve Damar Cerrahisi Kliniği, İstanbul, Türkiye
No information available.
No information available
Received Date: 26.10.2023
Accepted Date: 17.12.2023
Publish Date: 29.12.2023
PDF
Cite
Share
Request

ABSTRACT

Objective:

To investigate the effect of modified ultrafiltration (MUF) applied after cardiopulmonary bypass on clinical parameters in pediatric cardiac surgery in patients weighing less than 10 kg.

Materials and Methods:

Seventy patients weighing less than 10 kg, who underwent atrial septal defect and ventricular septal defect (VSD) procedures in the Pediatric CVS Clinic of Hospital, were divided into two comparative groups, with and without MUF, and their clinical parameters were retrospectively examined during the intraoperative and postoperative periods. For this purpose, the effect of MUF on inotrope score, balance in CPB, 24-hour urine amount, 24-hour drainage amount, intraoperative blood use after CPB, blood gas parameters, hemodynamic parameters, biochemical and infection parameters were compared.

Results:

Statistical differences were observed in CPB balance, the amount of erythrocytes used after CPB, pH, pO2, glucose, lactate, HCO3, pulse, mean arterial pressure, NIRS, hemoglobin, hematocrit, creatine, ALT, aPTT and INR values in patients who underwent MUF. A significant difference was detected.

Conclusion:

We think that MUF may positively affect clinical parameters in pediatric patients undergoing CPB and contribute to better results in the post-operative period. According to the results obtained in our study, we recommend the application of MUF after CPB in ASD and VSD procedures in pediatric cardiac surgery clinics.

References

1
Paç M, Akçevin A, Aka SA, Buket S, Sarıoğlu T. Kalp ve damar cerrahisi. Baskı, İstanbul: MN Medikal & Nobel 2004;151-167.
2
Boodhwani M, Hamilton A, de Varennes B, Mesana T, Williams K, Wells GA, et al. A multicenter randomized controlled trial to assess the feasibility of testing modified ultrafiltration as a blood conservation technology in cardiac surgery. J Thorac Cardiovasc Surg 2010;139(3):701-706.
3
Yokoyama K, Takabayashi S, Komada T, Onoda K, Mitani Y, Iwata H, et al. Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2009;137(3):730-735.
4
Naik SK, Elliott MJ. Ultrafiltration and pediatric cardiopulmonary bypass. Cardiology in the Young 1993;3(4):331-339.
5
Raja SG, Yousufuddin S, Rasool F, Nubi A, Danton M, Pollock J. Impact of modified ultrafiltration on morbidity after pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2006;14(4):341-350.
6
Ziyaeifard M, Alizadehasl A, Massoumi G. Modified ultrafiltration during cardiopulmonary bypass and postoperative course of pediatric cardiac surgery. Res Cardiovasc Med 2014;3(2):e17830.
7
Marinari E, Rizza A, Iacobelli R, Iodice F, Favia I, Romagnoli S, et al. Ventricular-Arterial Coupling in Children and Infants With Congenital Heart Disease After Cardiopulmonary Bypass Surgery: Observational Study. Pediatr Crit Care Med 2019;20(8):753-758.
8
Sever K, Tansel T, Basaran M, Kafali E, Ugurlucan M, Ali Sayin O, et al. The benefits of continuous ultrafiltration in pediatric cardiac surgery. Scand Cardiovasc J 2004;38(5):307-311.
9
Torina AG, Silveira-Filho LM, Vilarinho KA, Eghtesady P, Oliveira PP, Sposito AC, et al. Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study. J Thorac Cardiovasc Surg 2012;144(3):663-670.
10
Li J, Hoschtitzky A, Allen ML, Elliott MJ, Redington AN. An analysis of oxygen consumption and oxygen delivery in euthermic infants after cardiopulmonary bypass with modified ultrafiltration. Ann Thorac Surg 2004;78(4):1389-1396.
11
Bando K, Turrentine MW, Vijay P, Sharp TG, Sekine Y, Lalone BJ, et al. Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease. Ann Thorac Surg 1998;66(3):821-827; discussion 828.
12
Edmunds LH Jr. Advances in the heart-lung machine after John and Mary Gibbon. Ann Thorac Surg 2003;76(6):S2220-2223.
13
Davies MJ, Nguyen K, Gaynor JW, Elliott MJ. Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998;115(2):361-9; discussion 369-370.
14
Zakkar M, Guida G, Angelini GD. Modified ultrafiltration in adult patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg 2015;20(3):415-421.
15
Gaynor JW. The effect of modified ultrafiltration on the postoperative course in patients with congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2003;6:128-139.
16
Palanzo DA, Wise RK, Woitas KR, Ündar A, Clark JB, Myers JL. Safety and utility of modified ultrafiltration in pediatric cardiac surgery. Perfusion 2023;38(1):150-155.
17
Journois D, Israel-Biet D, Pouard P, Rolland B, Silvester W, Vouhé P, et al. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996;85(5):965-976.
18
Chew MS, Brix-Christensen V, Ravn HB, Brandslund I, Ditlevsen E, Pedersen J, et al. Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study. Perfusion 2002;17(5):327-333.
19
Suzuki H, Oshima N, Watari T. Effect of modified ultrafiltration on cytokines and hemoconcentration in dogs undergoing cardiopulmonary bypass. J Vet Med Sci 2020;82(11):1589-1593.
20
Sabuncu Ü, Özgök A. Serebral oksijen satürasyonu monitörizasyonunun rejyonel doku hipoksisini tespit etmedeki yeri 2016;125-127.
21
Raja SG, Yousufuddin S, Rasool F, Nubi A, Danton M, Pollock J. Impact of modified ultrafiltration on morbidity after pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2006;14(4):341-350.
22
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012;367(24):2296-2304.
23
Bozdoğan, D. Açık kalp cerrahisi uygulanan siyanotik/nonsiyanotik konjenital kalp hastalarında modifiye ultrafiltrasyonun postoperatif karaciğer ve böbrek fonksiyonları üzerine etkisi (Retrospektif çalışma) 2012.
24
Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105(2):234-241.
25
Landow L. Splanchnic lactate production in cardiac surgery patients. Crit Care Med 1993;21(2 Suppl):S84-91.
26
Mohanlall R, Adam J, Nemlander A. Venoarterial modified ultrafiltration versus conventional arteriovenous modified ultrafiltration during cardiopulmonary bypass surgery. Ann Saudi Med 2014;34(1):18-30.
27
McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001;17(1):107-124.
28
Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001;15(4):533-551.
29
Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997;95(7):1783-1790.